Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock

BEDFORD, Mass--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), today announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $5.00 per share for gross proceeds of $32.5 million. This offering was made pursuant to a shelf registration statement that was previously filed with and declared effective by the Securities and Exchange Commission (SEC). All of the shares in the offering are to be sold by the Company. In ad

Full Story →